NOS3 and hepatocellular carcinoma: The rs351855 (FGFR4) variant, in conjunction with a variant in the NOS3 gene not found in the indigenous population of our study, may serve as a prognostic marker for patients with hepatocellular carcinoma treated with lenvatinib16.